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Introduction
Tumorhypoglycemia is most commonly associated with insulinomas
secondary to insulin production by the islet-cell tumor. Insulino
mas are the most common pancreatic endocrine neoplasms. with
an incidence of one case per million per year. They are rarely
ectopic, with almost 100% ofdocumented tumors occurring within
the pancreas. The majority occur sporadically (> 90%) and are
solitary.3 Lesions occurring in the setting of multiple endocrine
neoplasia (MEN) type I syndrome constitute approximately 5% of
cases and may be multicentric within the pancreas.2
Almost all affected patients have symptoms due to hypoglycemia
and adhere to Whipple’s triad consists of: (I) symptomatic hypo
glycemia induced by fasting, (2) glucose levels less than 50 mg/dL.
and (3) relief of symptoms with administration of glucose.4These
criteria are fundamental forestablishing the diagnosis ofinsulinoma;
however, they may also be used to indicate that presenting symp
toms, in general, are caused by severe hypoglycemia.1In addition
to insulinomas, symptoms may arise from non-islet-cell tumors.
Doege reported the first case in 1930 when he described a patient
with a large fibrosarcoma and hypoglycemia. Since that time, a
number of similar cases have been described in the literature.5These
tumors are generally large, slow-growing, mesenchymal tumors
(e.g. sarcomas, fibromas, mesotheliomas, orhemangiopericytomas)
located in the retroperitoneum or thorax.6Theunderlying mechanism
of hypoglycemia appears to be the production of peptides with insu
lin-like structure and bioactivity that exerts an effect on the insulin
receptor.1
We describe a unique patient who presented with hypoglycemia
and a rapidly enlarging breast mass. Surgical resection revealed
a cystosarcoma phyllodes tumor with insulin-secreting epithelial
cells, We believe this to be the first reported case of a breast mass
causing severe non-islet-cell tumor hypoglycemia.
Case Report
A 33-year-old. nulliparous. Marshallese female presented to Majuro
Hospital in March, 2000 with complaints of generalized weakness.
At that time, she was found to be profoundly hypoglycemic. The
hypoglycemia responded only to infusion of D111, with occasional
need for D51 boluses, She had no history of diabetes mellitus and
denied taking any medications. Initial evaluation also revealed
massive enlargement of the left breast. She denied having any pain
or constitutional symptoms. The patient’s mother reported having
noticed the enlargement only 3 weeks earlier; however, sufficient
details regarding the breast enlargement were difficult to obtain
secondary to the patient’s mental derangement and the mother’s
poor history. Apart from her mental illness, the patient had no
significant past medical history. She had always been short and
small, hut otherwise developed normally until the age of 27 when
her mental status deteriorated abruptly. She stopped taking care
of her personal hygiene. often showing no interest in eating or her
own safety. Her sister had visited the Marshall Island within the
past year and had not noticed any breast enlargement at that time.
Menarche was at age 15 and she reported regular monthly cycles..
There was no family history of breast or ovarian cancers.
The patient was air evacuated to Tripler Army Medical Center,
where she was promptly taken to Emergency Room for deterioration
of her mental status. She was severely obtunded with questionable
airway compromise. On arrival, her serum glucose level was 55
mg/dL. Following an infusion of D, her glucose levels remained
low at 24 mg/dL. Additional glucose replacement finally succeeded
in normalizing her levels with subsequent improvement ofher mental
status. During her hospitalization, normal glucose levels could not
be sustained with regular meals; therefore, she was started on a D10
infusion, which was titrated to maintain euglycemia.
On physical examination, the left breast was massively enlarged
(Figure 1). There was a firm, freely mobile, non-tender mass involv
ing all four quadrants of the breast. The overlying skin was shiny
with mild hyperemia and visible, dilated veins. No discharge was
noted from either breast. Examination of the right breast revealed
two discrete, firm, mobile 1 cm nodules in the upper outer quadrant.
No axillary, supraclavicular, or infraclavicular lymphadenopathy
was noted, Examination of her skin revealed extremely small hands
and feet with multiple old scars on her lower extremities bilaterally
and lesions on her upper extremities in various states of healing.
Remainder of the physical examination was unremarkable.
The patient’s laboratory work-up was significant for: normal liver
function tests and pancreatic enzymes, a glucose of 25 mg/dL and
insulin level of 39 izU/mL while fasting, C-peptide = 0.4 ng/mL,
Insulin-like Growth Factor (IGF)-I 59 ng/mL, Insulin-like Growth
Factor (IGF)-II = 330 ng/mL, a random cortisol level of 8.8 ig/dL,
and a TSH = 1.62 ulU/mL.
Mammography showed diffuse enlargement of the left breast.
A core needle biopsy demonstrated that the mass was consistent
with fibroadenoma vs. cystosarcoma phyllodes tumor. Abdominal
ultrasound revealed a normal liver, gallbladder, and pancreas. CT
scan of the abdomen/pelvis, including her pancreas, did not show
any abnormalities.
She was taken for simple mastectomy on 15 May 2000. A firm,
irregular, lobulated mass measuring 18 x 16.5 x Il .5cm was excised.
Each lobule had a papillary appearance surrounded by a thick fibrous
rim with prominent vascular channels. The cut surfaces exuded
a scant amount of gelatinous to highly viscous clear fluid as well
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as multiple areas of cho’olatc bros n. distorted sacs. Pathologic
examination clas sitied the inas’ as a massive. lois —grade phx ilodes
tumor. Sections shon ed the tumor to he composed of broad leaf—like
processes ith spindled. mildix cellular stroma without cytologic
atvpia and univ rare mitotic tigures. Immunohistochemical stains
liar insulin ‘tere focail\ positi\ e in the epithelial cells (Figure 21.
Immunostains for CK1)03 and smooth muscle actin were also evalu
ated and revealed a mosaic pattern of staining in the hvperplastic
epithelium within the tumor.
The patient did well postoperatively with resolution of her hy
poglycemia. She u as discharged on post-operative day 3. She has
had no evidence of hvpoulycemia to date, on follow-up.
Discussion
We report a patient ss ith a laree. well—differentiated cystosarcoma
phvllodes tumor st ho presented with a history sieni licant for weak
ness. altered menial latus in the tasted state, and symptolns consistent
ss dli Vhipplc’ triad The difteicntial diaenosis liar such a patiem
L 01 ci c ,d a n id 1 h ,lx il I
patient as on no medications, ‘ionnil C-ocptide levels
factitious hs oeivecmd, Thus. ssc faa ucd on the
e the hkel culi it
The nialorita ofiosulinomux am less than 7. cm, benign, and. w .1 it.arv,”
Thc are almost cxcioi intrapancreatic, with approximated
tI tumors being located in the body and tail of the pane reas.
to the left of the supurior mesenteric arteryd This distributi.on seems
to correspond to the normal distribution of insui.i..n cells with.i.n the
pancreas. Howes en up to ten percent of i.n.suhnomas are• malignant.
and thus, ntetastatic Metastases are found most commonly in the.
surrou.nding ‘mpti nodes a.nd liver. Furthermttre, muiti.centric. le
sions are found in the meonitv of pat.ient.s with MEN I syndrome.
Radiological studie.s in our patient failed to detect any suspicious
masses in the pancreas; therefore, we suspec.ted. her breast mass to
Ic tb. primary source of h..er symptom
Ectopic insulinomas are exceptionally rare. A retrospective study
by the Mayo Clinic examined the institution’s sixty-yearexperience
with insulinoms from 1927 to I 9867 This investigation described
only one ecu pie tumor in a cohort of 194 patientsd Although the
specific location of this trunor was not discussed, the surgical pro
cedures for all patients in the study were intraahdominal, suggesting
its development st ithin the abdomen, No ectopic insulinomas were
reported in additional studies that encompassed over three decades
of clinical experience. A Medline literature review from the
years 1902 to 2003 found no record of an insulinoma presenting as
a breast mass.
Ci.)re biopsies of the patient’s breast mass indicated that it was
I ikelv a c stosarcoma phvl lodes. an uncommon fibroepithelial neo—
plasm of the breast that accounts for 0.3-0.9fa of all breast cancers
in females. Although similar in structure to a fibroadenoma, the
tumor may be distinguished histologically by large leaf—like projec
tions of stronla with increased strornal cellularity. -‘The biological
behavior of these tumors is highlr variable, and the criteria for
differentiating between malignant and benign neoplasms remain
poorl delined. Surgery is the primary mode of treatment .Although
radical mastectom\ tt as performed in the past. more conserva
tive approaches are noss recommended. Currently, the choice is
made between ts ide local excision with I cm margins vs. simple
mastectom\ without a\illarv clearance.’1 While recurrences are
not unc( mnion with these lesions, a number of recent studies have
shott n that wide local excision with negative margins yields local
control rates ot approximatel\ 99( ‘ Due to the laree size of the
tumor in our patent. we elected to perform a simple mastec tom\.
Pathologic ret en ret caled a cr stosarcoma phvliodes tumor n ith
insulin-secreting epithelial cells. The absence of islet-cells suggested
that this mass, although insulin—secreting, was not of pancreatic
origin, and thus St as not an ectopic insulinoma.
Although non-islet-cell tumor hypoglycemia (NICTH) has been
reported in several neoplasms of mesodermal and epithelial origin.
to our knots ledge. there have been no cases of NICTH in patients
with cystosarcoma phllodes. The tumors tend to he large and
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welhdifferentiated, as in our patient. However, patients with NICTH
generally demonstrate low or unmeasureable levels ol serum insulin
during hypoglycemic episodes. Recent studies have explained this
paradox by suggesting that peptides with an insulin-like structure,
especially insulindike growth factor (lGFhll and an incompletely
processed IGFII propeptide (“big” IGF-ll), may he responsible.
In contrast to this typical presentation of MUTE-I, our patient was
found to have elevated insulin levels as well as decreased levels of
IGF—l and IGF—II. Histological evaluation of the tumordemonstrated
insulin-secreting cells.
Medical treatment thr insulinomas and NICTH-causing lesions
is generally either palliative or used only while awaiting surgical
excision of the lesionle Surgical therapy is typically curative and
continued hypoglycemia following tumor resection is suspicious
for the presence of multicentric lesions or metastases. Surgery
is also the mainstay of treatment for patients with cystosarcoma
phyllodes. Our case is interesting in that etiology of our patient’s
hypoglycemia was an insulin-secreting cystosarcoma phyllodes.
Furthermore, histological and laboratory evaluation revealed that
the lesion was neither a true ectopic insulinoma, nor was it typical
of a NICTH-causing tumor. Despite these unique characteristics,
definitive treatment was straightforward. Simple mastectomy of
the affected breast provided complete resection of neoplastic tissue
in addition to resolution of the patient’s hypoglycemia. In the end,
this case serves to illustrate another rare, but plausible, culprit in
the differential of tumor—induced hypoglycemia.
This article contains the opinions of the authors only and does not
represent the opInIons oft/ic United States Department of Defense
or the United States Army.
References
Tietge 1j,J,E, SchOfi C, Ocran KW, et aL Hepatoma with Severe Non-Islet Cci Tumor Hypoglycem[a.
The American Journal of Gastroenterology 93(6): 9971000, 1998.
2. Bieligk 5, Jaffe SM. Islet Cell Tumors of the Pancreas. Surgical Clinics of North America 75(5): 1 025-
40, 1995.
3. Dolan JR Norton JA. Occult Insulinoma, British Journal of Surgery 87: 385-7, 2000.
4. Grant CS. tfsulinoma, Surgical Oncology Clinics of North America 714): 819-44, 1998.
5. Daughaday WH, Emanuele MA, Brooks MH, ef al. Synthesis and Secretion of Insulin-Like Growth
Factor Il by a Leiomyosarcoma with Associated Hypoglycemia, The New England Journal of Medicine
31 9(22): 1434-40. 1988.
6. Auelrod L, Ron D. Insulin-Like Growth Factor II and the Riddle of Tumor-Induced Hypoglycemia. The
New England Journal of Medicine 319(22): 1477-9, 1988.
7. Richards ML, Gauger PG. Thompson NW, et al, Pitfalls in the Surgmal Treatment of Insulinoma,
Surgery 132(6): t040-9, 2002.
8. Howard TJ, Stabile BE. Zinner MJ, et al, Anatomic Oistribution of Pancreatic Endocrine Tumors. The
American Journal of Surgery 159: 258-64, 1990.
9. Service FJ, McMahon MM, O’Brien PC, Ballard DJ. Functioning Insulinoma — Incidence, Recurrence,
and Long-Term Survival of Patients: A fioYears Study. Mayo Clinic Proceedings 66: 711-9, 1991.
10. Jordan, PH. A Personal Experience with Pancreatic and Duodenal Neuroendocrine Tumors, Journal
of the Amerrcan College of Surgeons 189(5): 470-82. t999.
11, Menegauv F Schmitt G, et al, Panc.reatic Insulinomas, The American Journal of Surgery 165:243-8,
1993.
12. Pandey M, Mathew A, Kattoor J, et al. Malignant Phyllodes Tumor, The Breast Journal 7)6): 411 -6,
2001.
13. Chancy AW, Poliack A, Mcneese MD, et ai. Primary Treatment of Cystosarcoma Phyllodes of the
Breast, Cancer 89(7): 150211 2000.
FIVE
WAYS
TODIE
ONTHE
GOLF
COURSE:
1. Hit by a golf ball,
2. Run over by a golf cart.
3, Whacked by a golf club.
4. Struck by lightning.
5, Forgot your hat.
Surprisingly one million new
cases of skin cancer are
detected evenj year, One
person an hour in the u.S. dies
horn, melanoma, the deadliest
form cf skin cancer. If cu
spend a’ let of time in the sun,
you should nrotect’ yourself.
One out of five Am.ericans
develops skin cancer during
thei.r lifetime. Don)t be one o.f
them. Stay out of the midday
sun, Cover up. Whar a hat.
Seek shade. And use sunscreen.
For m.ore infdrmation on how
t.o prote•.t yourself from ski.n
ca.ncer, call I-888-462-DERM
or vissit wwvaaad.o’rg.
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